-
Gut Microbes Combine To Cause Colon Cancer, Study Suggests
The New York Times | Two types of bacteria common in the gut may accelerate the growth of tumors, suggesting new possibilities for diagnosis and prevention.
Feb 5, 2018
-
Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion
Forbes | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors.
Feb 2, 2018
-
IBM Brings V100 GPUs To Its Cloud
TOP500 | The popularity of NVIDIA's Tesla V100 GPUs got another boost this week with IBM's announcement that it has added them to its cloud offerings.
Feb 2, 2018
-
Certara Acquires BaseCase, A Life Sciences Data Visualization Company
Bio-IT World Brief | Certara today announced that it has acquired BaseCase, a data visualization software as a service company who has extensive Health Economics and Outcomes Research expertise and is actively working in the area of market access.
Feb 1, 2018
-
The Doctor Responsible For Gene Therapy’s Greatest Setback Is Sounding A New Alarm
MIT Technology Review | Toxic effects seen in animals raise questions about new gene therapies for children.
Jan 31, 2018
-
Transpacific Biotech Startup Combines Asian Investors And Some Seriously Trendy Science Out Of MIT
ENDPOINTS NEWS | Engine Biosciences plans to integrate AI and machine learning with hands-on lab work in drug development to create a whole new kind of drug development platform.
Jan 31, 2018
-
A Biopharma Innovator's Wish List For President Trump
STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.
Jan 30, 2018
-
Will America Yield Its Position As The World’s Leader In Science And Technology?
BostonGlobe | For the first time since World War II, America's primacy in science and technology is in jeopardy. Choices that the country makes today will determine whether it continues to reap the rewards that come from being at the cutting edge.
Jan 29, 2018
-
Oxford Nanopore MinION Used To Produce Most Complete Human Genome
Bio-IT World A paper published today in Nature Biotechnology, reports Oxford Nanopore sequencing resulting in the most complete human genome ever assembled with a single technology.
Jan 29, 2018
-
Genedata, Congenica, Nanome, And More: News From January 2018
Bio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Genedata, Congenica, Nanome, and more.
Jan 29, 2018
-
Video: The Hyve Discusses Health Data Research Infrastructures, IoT In Webinar
Bio-IT World | In a recent webinar, Kees Bochove of The Hyve delved into consent, GDPR, the healthcare professional’s role in infrastructure, FAIR principles, open source solutions, the future of wearables, and much more.
Jan 26, 2018
-
The Cult Of DNA-centricity
Forbes | All of biology lies in the genome, right? That's a premise of modern medicine: a disease-free utopia based on gene therapy and, soon, gene editing. But what if the real answers lie in your proteins? DNA-centric thinking is holding back the next wave of cures for diseases like Alzheimer's.
Jan 25, 2018
-
BGI Increases Long-Read Sequencing Capacity With Purchase Of 10 PacBio Sequel Systems
Bio-IT World Brief | BGI and Pacific Biosciences today announced an agreement by BGI Genomics to purchase an additional 10 Sequel Systems, significantly expanding the capacity for Single Molecule, Real-Time Sequencing for BGI’s global sequencing service business.
Jan 25, 2018
-
VA Data And DOE Supercomputers Converge
Bio-IT World | A joint initiative between the Department of Energy and the U.S. Department of Veterans Affairs is using supercomputers to collect genetic, military exposure, lifestyle, and health information about veterans that can be used to understand how genes affect health and illness.
Jan 24, 2018
-
Why Celgene's Acquisition Of Juno Matters For Biotech And Investors
Forbes | Celgene just acquired immunotherapy biotech Juno Therapeutics in a $9 billion dollar deal. The deal will allow Celgene to compete in a space already occupied by Novartis and Gilead as they vie for hegemony in a new field of oncology.
Jan 23, 2018
-
Packing A Genome, Step-by-Step
HHMI | For the first time, scientists can see in minute-time resolution how cells package chromosomes into highly condensed structures prior to cell division.
Jan 19, 2018
-
CRISPR And Reddit: Doudna Hosts “Ask Me Anything” Session
Bio-IT World | Jennifer Doudna hosted an “Ask Me Anything” session on Reddit with assistance from her colleagues at Doudna Lab and at the National Human Genome Research Institute. Topics from the session include CRISPR/Cas9 litigation, potential immunity to CRISPR, Designer Babies, and more.
Jan 19, 2018
-
PacBio Outlook 2018
Omics! Omics! | Keith Robison gives his take on PacBio's recent presentation at the JP Morgan Healthcare Conference.
Jan 18, 2018
-
Why Gene Therapy Is No Longer A Pipe Dream
Pacific Standard | After decades of disappointment, cures to once-incurable diseases seem within reach.
Jan 18, 2018
-
Celgene In Talks To Buy Juno Therapeutics
New York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.
Jan 17, 2018